title: Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies.
authors.affiliation: Division of Pharmacometrics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration. Yaning.Wang@fda.hhs.gov
authors.forename: Yaning
authors.initials: Y
authors.lastname: Wang
authors.forename: Pravin R
authors.initials: PR
authors.lastname: Jadhav
authors.forename: Mallika
authors.initials: M
authors.lastname: Lala
authors.forename: Jogarao V
authors.initials: JV
authors.lastname: Gobburu
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D008954:Models, Biological; D010599:Pharmacokinetics; D018401:Sample Size